Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working party : Outcome Measures in RheumatologyGAZARIAN, M; TUGWELL, P; BOERS, M et al.Journal of rheumatology. 1999, Vol 26, Num 1, pp 207-209, issn 0315-162XConference Paper

Sensitivity to change of generic Quality of Life instruments in patients with Rheumatoid arthritis : Preliminary findings in the generic Health OMERACT study : Outcome Measures in RheumatologyWELLS, G; BOERS, M; SHEA, B et al.Journal of rheumatology. 1999, Vol 26, Num 1, pp 217-221, issn 0315-162XConference Paper

Report of the OMERACT Task Force on economic evaluation : Outcome Measures in RheumatologyGABRIEL, S; TUGWELL, P; O'BRIEN, B et al.Journal of rheumatology. 1999, Vol 26, Num 1, pp 203-206, issn 0315-162XConference Paper

Outcome measures in rheumatologyJournal of rheumatology. 1999, Vol 26, Num 1, pp 199-228, issn 0315-162XConference Proceedings